Center Laboratories, Inc. (TPEX:4123)

Market Cap	28.07B
Revenue (ttm)	1.60B
Net Income (ttm)	-667.63M
Shares Out	710.52M
EPS (ttm)	-0.92
PE Ratio	n/a
Forward PE	n/a
Dividend	0.75 (1.90%)
Ex-Dividend Date	Oct 3, 2025

Volume	1,170,000
Average Volume	2,096,384
Open	39.15
Previous Close	39.15
Day's Range	39.00 - 39.50
52-Week Range	30.60 - 52.00
Beta	0.40
RSI	55.98
Earnings Date	Nov 12, 2025

About Center Laboratories

Center Laboratories, Inc., a pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally. The company offers general medication pharmaceuticals comprising of antipyretic and analgesic, bronchodilator, anti-inflammatory preparations, anti-allergic agent, expectorant, narcotic antitussive and expectorant, gastrointestinal preparations, non-narcotic antitussive and expectorant, and other medicines. It also offers central nervous system medication consisting of cerebrovascular disease, dementia, depressi...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1959
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4123

Financial Performance

In 2024, Center Laboratories's revenue was 1.62 billion, an increase of 16.06% compared to the previous year's 1.39 billion. Losses were -1.10 billion, 10.9% more than in 2023.